Literature DB >> 17606135

Prevention of infection in peripheral arterial reconstruction: a systematic review and meta-analysis.

Andrew H Stewart1, Paul S Eyers, Jonothan J Earnshaw.   

Abstract

OBJECTIVE: The aim of this systematic review and meta-analysis was to determine the effectiveness of perioperative strategies to prevent infection in patients undergoing peripheral arterial reconstruction.
METHODS: All randomized controlled trials (RCTs) evaluating measures intended to reduce or prevent infection in arterial surgery were identified through searches of the Cochrane Peripheral Vascular Diseases Group specialized trials register, the Cochrane Central Register of Controlled Trials (CENTRAL), and reference lists of relevant articles. Two authors independently selected and assessed the quality of included trials. Relative risk (RR) was used as a measure of effect for each dichotomous outcome.
RESULTS: The study included 34 RCTs. Of these, 22 were trials of prophylactic systemic antibiotics, 3 of rifampicin-bonded grafts, 3 of preoperative skin antisepsis, 2 of suction wound drainage, 2 of minimally invasive in situ bypass techniques, and individual trials of intraoperative glove change and wound closure techniques. Wound infection or early graft infection outcomes were recorded in all trials. Only two trials, both of rifampicin bonding, followed up graft infection outcomes to 2 years. Prophylactic systemic antibiotics reduced the risk of wound infection (RR, 0.25; 95% confidence interval [CI], 0.17 to 0.38) and early graft infection in a fixed-effect model (RR, 0.31; 95% CI, 0.11 to 0.85, P = .02). Antibiotic prophylaxis for >24 hours appeared to be of no added benefit (RR, 1.28; 95% CI, 0.82 to 1.98). There was no evidence that prophylactic rifampicin bonding to Dacron grafts reduced graft infection at 1 month (RR, 0.63; 95% CI, 0.27 to 1.49), or 2 years (RR, 1.05; 95% CI, 0.46 to 2.40). There was no evidence of a beneficial or detrimental effect on rates of wound infection with suction groin wound drainage (RR, 0.96; 95% CI, 0.50 to 1.86) or from preoperative bathing with antiseptic agents compared with unmedicated bathing (RR, 0.97; 95% CI, 0.70 to 1.36).
CONCLUSIONS: There is clear evidence of the benefit of prophylactic broad-spectrum antibiotics for vascular reconstruction. Many other interventions intended to reduce the risk of infection in arterial reconstruction lack evidence of effectiveness.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17606135     DOI: 10.1016/j.jvs.2007.02.065

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  12 in total

Review 1.  [Postoperative complications in vascular surgery].

Authors:  H Diener; A Larena-Avellaneda; E S Debus
Journal:  Chirurg       Date:  2009-09       Impact factor: 0.955

Review 2.  Prophylactic antibiotics for percutaneous endovascular procedures.

Authors:  N S Greaves; E Katsogridakis; B Faris; D Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-06       Impact factor: 3.267

3.  Which prosthesis is more resistant to vascular graft infection: polytetrafluoroethylene or Omniflow II biosynthetic grafts?

Authors:  Orhan Bozoglan; Bulent Mese; Erdinc Eroglu; Serdal Elveren; Mustafa Gul; Ahmet Celik; Halil Ibrahim Yildirimdemir; Harun Ciralik; Alptekin Yasim
Journal:  Surg Today       Date:  2015-03-06       Impact factor: 2.549

Review 4.  Antimicrobial prophylaxis in adults.

Authors:  Mark J Enzler; Elie Berbari; Douglas R Osmon
Journal:  Mayo Clin Proc       Date:  2011-07       Impact factor: 7.616

Review 5.  [Aortofemoral vascular graft infections and their prevention].

Authors:  F Taher; O Assadian; K Hirsch; J Falkensammer; C Senekowitsch; A Assadian
Journal:  Chirurg       Date:  2015-03       Impact factor: 0.955

6.  Nationwide Trends in Hospital Outcomes and Utilization After Lower Limb Revascularization in Patients on Hemodialysis.

Authors:  Pranav S Garimella; Poojitha Balakrishnan; Ashish Correa; Priti Poojary; Narender Annapureddy; Kinsuk Chauhan; Achint Patel; Shanti Patel; Ioannis Konstantinidis; Lili Chan; Shiv Kumar Agarwal; Bernard G Jaar; Umesh Gidwani; Kunihiro Matsushita; Girish N Nadkarni
Journal:  JACC Cardiovasc Interv       Date:  2017-10-23       Impact factor: 11.195

7.  Sustained release of vancomycin from novel biodegradable nanofiber-loaded vascular prosthetic grafts: in vitro and in vivo study.

Authors:  Kuo-Sheng Liu; Cheng-Hung Lee; Yi-Chuan Wang; Shih-Jung Liu
Journal:  Int J Nanomedicine       Date:  2015-01-29

8.  Surgical and antimicrobial treatment of prosthetic vascular graft infections at different surgical sites: a retrospective study of treatment outcomes.

Authors:  Stefan Erb; Jan A Sidler; Luigia Elzi; Lorenz Gurke; Manuel Battegay; Andreas F Widmer; Maja Weisser
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

9.  Efficacy of Preoperative Antibiotic Therapy for the Treatment of Vascular Graft Infection.

Authors:  Takuya Miyahara; Katsuyuki Hoshina; Masahiko Ozaki; Masanori Ogiwara
Journal:  Ann Vasc Dis       Date:  2018-06-25

10.  Negative Pressure Incision Management System in the Prevention of Groin Wound Infection in Vascular Surgery Patients.

Authors:  Jan H Koetje; Karsten D Ottink; Iris Feenstra; Wilbert M Fritschy
Journal:  Surg Res Pract       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.